Skip to main content
MedVellum
MCQsExamsAtlas
DashboardPricing
MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳MBBS / Core medicine✳Dermatology✳ICU Fellowship (CICM)✳Anaesthesia✳Emergency Medicine✳Psychiatry Fellowship✳Paediatrics Fellowship✳Physician Medicine✳MCQs✳SAQs✳Vivas✳OSCE✳Evidence-first✳

MedVellum.

The folio

Exam-exhaustive medical education across every specialty — evidence-graded topics, engraved plates, and practice in every written and oral format. Educational content only — not medical advice.

llms.txt · psychiatry LLM catalog · sitemap

Atlas

  • Specialty atlas
  • MBBS / Core medicine
  • Dermatology
  • ICU Fellowship (CICM)
  • Anaesthesia
  • Emergency Medicine
  • Psychiatry Fellowship
  • Paediatrics Fellowship
  • Physician Medicine

Study & account

  • MCQ practice
  • Practice alias
  • Exam tools
  • Dashboard
  • Pricing
  • Sign in

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

Folio edition · Set in Instrument Serif & Archivo

Phys Vivasendocrine

Phys Vivas · endocrine

Reproductive Endocrinology — Viva Defence

DCE viva defence for Reproductive Endocrinology.

On this page & tools

Target exams

FRACP DCEMRCP PACES

Target exams

FRACP DCEMRCP PACES
Prompt
DCE viva defence for Reproductive Endocrinology.

Reproductive Endocrinology Viva

Long Case Viva Defence

Opening statement

"This patient presents with a problem best framed as Reproductive Endocrinology. My priorities are to identify red flags, confirm the mechanism with purposeful investigations, start a sequenced management plan, and integrate multimorbidity and follow-up." [1] [2]

Examiner questions

Q1: "What makes this urgent?" [1]

"I look for threats to airway, perfusion, neurology, metabolism, infection or bleeding, and I escalate those before elective work-up." [1] [2]

Q2: "What is your first investigation package?" [2]

"I order tests that change management now, not a scattergun panel." [1] [2]

Q3: "Walk me through treatment." [1]

"Stabilise, treat the mechanism, prevent complications, and plan monitoring." [1] [2] [3]

Q4: "What is the classic trap?" [2]

"Treating a label without confirming the discriminating mechanism, or delaying escalation." [1] [2]

Short case

Counsel the patient on the plan, risks and warning symptoms in plain language. [1] [2]

References

  1. [1]Castaneda R, Tatit CP, Hurtado Andrade MD, Faubion SS, et al. Dyslipidemia across the menopause transition: Mechanisms, trajectories, and opportunities for cardiovascular prevention Maturitas, 2026.PMID 42468089
  2. [2]Hadji P, Athanasiadis A, Brandi ML, Chakhtoura M, et al. Pregnancy- and lactation-associated osteoporosis: A position statement of the IAPM, IOF, ECTS, ESCEO, IMS, and EMAS Int J Gynaecol Obstet, 2026.PMID 42464584
  3. [3]Wanjari UR A review on molecular regulation of male reproductive hormones and signaling pathways: Emerging mechanisms and research gap Tissue Cell, 2026.PMID 42462599
  4. [4]Xia L, Li F, Yin D, Wei T, et al. Glucagon receptor blockade protects spermatogenesis by enhancing PFKFB3-mediated lactate production in Sertoli cells J Transl Med, 2026.PMID 42458466
  5. [5]Korneyev I A, Apolikhin O I, Babenko A Y, Bogolyubov S V, et al. [Male infertility and reproductive dysfunction: clinical aspects of the use of terms and definitions from the Russian Society of Urology guidelines] Urologiia, 2026.PMID 42417363
  6. [6]ESHRE Good Practice in the IVF Lab Working Group, Arroyo G, Barrie A, Coticchio G, et al. ESHRE recommendations on Good Practice in the IVF laboratory† Hum Reprod, 2026.PMID 42405499
  7. [7]Xi Y, Yao T, Zhang C, Zhuang T Effectiveness of safety care and clinical nursing pathway in patients undergoing cardiovascular intervention: a randomized controlled trial Perioper Med (Lond), 2026.PMID 42469924
  8. [8]Marks FJ, Walters SJ, Sutton L, Jacques RM What statistical methods are more appropriate for predicting recruitment at the design stage of a randomised controlled trial? Trials, 2026.PMID 42469922